Moxidectin
(right click,save link as to download,it is a temp file,please download as soon as possible, you can also use CTRL+S to save the whole html page)
Basic Info
Common Name | Moxidectin(F05784) |
2D Structure | |
FRCD ID | F05784 |
CAS Number | 113507-06-5 |
PubChem CID | 9832912 |
Formula | C37H53NO8 |
IUPAC Name | None |
InChI Key | YZBLFMPOMVTDJY-LSGXYNIPSA-N |
InChI | InChI=1S/C37H53NO8/c1-21(2)14-25(6)33-26(7)31(38-42-8)19-36(46-33)18-29-17-28(45-36)13-12-23(4)15-22(3)10-9-11-27-20-43-34-32(39)24(5)16-30(35(40)44-29)37(27,34)41/h9-12,14,16,21-22,26,28-30,32-34,39,41H,13,15,17-20H2,1-8H3/b10-9+,23-12+,25-14+,27-11+,38-31+/t22-,26-,28+,29-,30-,32+,33+,34+,36-,37+/m0/s1 |
Canonical SMILES | CC1CC(=CCC2CC(CC3(O2)CC(=NOC)C(C(O3)C(=CC(C)C)C)C)OC(=O)C4C=C(C(C5C4(C(=CC=C1)CO5)O)O)C)C |
Isomeric SMILES | C[C@@H]\1C/C(=C/C[C@@H]2C[C@@H](C[C@@]3(O2)C/C(=N\OC)/[C@@H]([C@H](O3)/C(=C/C(C)C)/C)C)OC(=O)[C@@H]4C=C([C@H]([C@@H]5[C@]4(/C(=C/C=C1)/CO5)O)O)C)/C |
Synonyms | Moxidectin ProHeart 6 113507-06-5 UNII-NGU5H31YO9 Cydectin NGU5H31YO9 Moxidectine [INN-French] Moxidectinum [INN-Latin] Moxidectina [INN-Spanish] C37H53NO8 |
Classifies | Veterinary Drug |
Update Date | Nov 13, 2018 17:07 |
Chemical Taxonomy
Kingdom | Organic compounds |
Superclass | Phenylpropanoids and polyketides |
Class | Macrolides and analogues |
Subclass | Milbemycins |
Intermediate Tree Nodes | Not available |
Direct Parent | Milbemycins |
Alternative Parents | |
Molecular Framework | Aliphatic heteropolycyclic compounds |
Substituents | Milbemycin - Ketal - Oxane - Tertiary alcohol - Tetrahydrofuran - Carboxylic acid ester - Lactone - Oxime ether - Secondary alcohol - Acetal - Carboxylic acid derivative - Dialkyl ether - Ether - Monocarboxylic acid or derivatives - Oxacycle - Organoheterocyclic compound - Organopnictogen compound - Organic oxygen compound - Carbonyl group - Alcohol - Organonitrogen compound - Organooxygen compound - Organic oxide - Hydrocarbon derivative - Organic nitrogen compound - Aliphatic heteropolycyclic compound |
Description | This compound belongs to the class of organic compounds known as milbemycins. These are a group of macrolides with a structure containing a 16-membered lactone ring fused to a 1,7-dioxaspiroundecane ring system and to either a benzofuran (or hydrogenated derivative thereof). In some cases (e.g. Milbemycin E), the tetrahydrofuranyl ring is missing. Milbemycins can be o-glycosylated at C13 to form Avermectins. Milbemycins are produced by Streptomyces species. |
Properties
Property Name | Property Value |
---|---|
Molecular Weight | 639.83 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 9 |
Rotatable Bond Count | 3 |
Complexity | 1340 |
Monoisotopic Mass | 639.377 |
Exact Mass | 639.377 |
XLogP | 4.3 |
Formal Charge | 0 |
Heavy Atom Count | 46 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 5 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
ADMET
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB- | 0.8767 |
Human Intestinal Absorption | HIA+ | 0.9507 |
Caco-2 Permeability | Caco2- | 0.6304 |
P-glycoprotein Substrate | Substrate | 0.7577 |
P-glycoprotein Inhibitor | Inhibitor | 0.7582 |
Inhibitor | 0.8387 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.6967 |
Distribution | ||
Subcellular localization | Mitochondria | 0.5842 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8261 |
CYP450 2D6 Substrate | Non-substrate | 0.8339 |
CYP450 3A4 Substrate | Substrate | 0.7713 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8263 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.7768 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9168 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7276 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8005 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8097 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9874 |
Non-inhibitor | 0.8251 | |
AMES Toxicity | Non AMES toxic | 0.6021 |
Carcinogens | Non-carcinogens | 0.9079 |
Fish Toxicity | High FHMT | 0.9809 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9812 |
Honey Bee Toxicity | High HBT | 0.7533 |
Biodegradation | Not ready biodegradable | 0.9678 |
Acute Oral Toxicity | III | 0.6010 |
Carcinogenicity (Three-class) | Non-required | 0.4891 |
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -3.6391 | LogS |
Caco-2 Permeability | 0.6524 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.7766 | LD50, mol/kg |
Fish Toxicity | 0.8666 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.7045 | pIGC50, ug/L |
MRLs
Food | Product Code | Country | MRLs | Application Date | Notes |
---|---|---|---|---|---|
Muscle Of Sheep | United States | 5oppb | |||
Liver Of Sheep | United States | 200ppb | |||
Fat Of Sheep | United States | 300ppb | |||
Muscle Of Cattle | United States | 5oppb | |||
Liver Of Cattle | United States | 200ppb | |||
Fat Of Cattle | United States | 300ppb | |||
Milk | Japan | 0.04ppm | |||
Other Terrestrial Mammals,Edible Offal(Excep Deer) | Japan | 0.05ppm | |||
Deer,Edible Offal | Japan | 0.2ppm | |||
Cattle,Edible Offal | Japan | 0.5ppm | |||
Other Terrestrial Mammals,Kidney(Except Sheep And Deer) | Japan | 0.05ppm | |||
Other Terrestrial Mammals,Liver(Except Sheep And Deer) | Japan | 0.1ppm | |||
Other Terrestrial Mammals,Fat(Except Sheep And Deer) | Japan | 0.5ppm | |||
Other Terrestrial Mammals,Muscle(Except Sheep And Deer) | Japan | 0.05ppm | |||
Deer,Kidney | Japan | 0.05ppm | |||
Sheep,Kidney | Japan | 0.05ppm | |||
Cattle,Kidney | Japan | 0.05ppm | |||
Sheep,Liver | Japan | 0.10ppm | |||
Cattle,Liver | Japan | 0.10ppm | |||
Deer,Fat | Japan | 0.50ppm |
References
Title | Journal | Date | Pubmed ID |
---|---|---|---|
Effects of the Antiparasitic Drug Moxidectin in Cattle Dung on Zooplankton and Benthic Invertebrates and its Accumulation in a Water-Sediment System. | Arch Environ Contam Toxicol | 2018 Aug | 29846763 |
A multi-country study to assess the effect of a treatment with moxidectin pour-onduring the dry period on milk production in dairy cows. | Vet Parasitol | 2017 Apr 15 | 28259556 |
The Anthelmintic Ingredient Moxidectin Negatively Affects Seed Germination ofThree Temperate Grassland Species. | PLoS One | 2016 Nov 15 | 27846249 |
Multiresidue method for simultaneous analysis of aflatoxin M1, avermectins, organophosphate pesticides and milbemycin in milk by ultra-performance liquid chromatography coupled to tandem mass spectrometry. | Food Addit Contam Part A Chem Anal Control Expo Risk Assess | 2016 Jun | 27144891 |
P-gp substrate-induced neurotoxicity in an Abcb1a knock-in/Abcb1b knock-out mouse model with a mutated canine ABCB1 targeted insertion. | Res Vet Sci | 2013 Jun | 23186803 |
Relative neurotoxicity of ivermectin and moxidectin in Mdr1ab (-/-) mice and effects on mammalian GABA(A) channel activity. | PLoS Negl Trop Dis | 2012 | 23133688 |
Fecal egg count reductions and performance effect of Dectomax, Cydectin, andCydectin plus Synanthic as used in feedlot steers. | Vet Ther | 2007 Winter | 18183550 |
Combining the effects of supplementary feeding and copper oxide needles for thecontrol of gastrointestinal nematodes in browsing goats. | Vet Parasitol | 2007 May 15 | 17400391 |
Improving resilience against natural gastrointestinal nematode infections inbrowsing kids during the dry season in tropical Mexico. | Vet Parasitol | 2006 Jan 30 | 16203095 |
Endectocide use in cattle and fecal residues: environmental effects in Canada. | Can J Vet Res | 2006 Jan | 16548326 |
The effect of supplementary feeding on the resilience and resistance of browsing Criollo kids against natural gastrointestinal nematode infections during therainy season in tropical Mexico. | Vet Parasitol | 2004 Oct 5 | 15381302 |